Nov (NOV) EBIT (2009 - 2026)

Nov (NOV) has 18 years of EBIT data on file, last reported at $119.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 21.71% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $461.0 million (down 46.77% YoY), and the FY2025 full-year result was $494.0 million, down 43.61% from the prior year.
• EBIT climbed to $119.0 million in Q1 2026, from $92.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $313.0 million in Q2 2024 to a low of -$21.0 million in Q1 2022.
• A 5-year average of $141.4 million and a median of $152.0 million in 2025 frame the typical range for EBIT.
• Across the five-year window, EBIT surged 1180.0% in 2022 and slumped 55.56% in 2025, its largest moves.
• Tracing NOV's EBIT over 5 years: stood at $162.0 million in 2022, then dropped by 0.62% to $161.0 million in 2023, then grew by 28.57% to $207.0 million in 2024, then tumbled by 55.56% to $92.0 million in 2025, then climbed by 29.35% to $119.0 million in 2026.
• Business Quant data shows NOV's EBIT at $119.0 million in Q1 2026, $92.0 million in Q4 2025, and $107.0 million in Q3 2025.